Skip to main content

Table 1 Mechanisms by which the gut microbiota remolds TME to promote CRC metastasis in different ways

From: Role of imbalanced gut microbiota in promoting CRC metastasis: from theory to clinical application

Microbiota

Result

Mechanism

Experimental method

References

F. nucleatum

recruit tumour-infiltrating

immune cells

F. nucleatum can recruit MDSCs and TAMs in TME, causing a decrease in CD8+ T cell density to suppress immunity in CRC patients, thereby promoting CRC metastasis.

in vitro

[61]

  

F. nucleatum induces the expression of the DAMP molecule S100A9 in CRC cells and subsequent M2 macrophage polarization via activating the TLR4/NF-κB signaling pathway.

in vitro

[66]

  

F. nucleatum infection activates the IL-6/p-STAT3/c-MYC signaling pathway in a TLR4-dependent way to increase M2 macrophage polarization and promote CRC growth and metastasis.

in vitro and in vivo

[67]

  

F. nucleatum promotes macrophage infiltration through activation of the chemokine CCL20, and induces M2 macrophage polarization, enhancing CRC metastasis.

in vitro

[74]

 

promote cell adhesion

F. nucleatum can promote adhesion of CRC cells to endothelial cells by inducing the ALPK1/NF-κB/ICAM1 axis, thus promoting extravasation and metastasis.

in vitro and in vivo

[68]

 

induce the secretion of pre-metastatic cytokines

F. nucleatum drives metastasis by selectively inducing pro-inflammatory and pro-metastatic cytokines IL-8 and CXCL1 from CRC cells via the bacterial surface adhesin Fap2.

in vitro

[75]

  

F. nucleatum binds to the E-cadherin receptor to cause the activation of β-catenin and stimulates the expression of pro-inflammatory cytokines.

in vivo

[76]

 

regulate tumour metabolism

F. nucleatum nucleatum increases CRC glycolysis by targeting the lncRNA ENO1-IT1 and the KAT7 histone modification axis, which is an important promoter of CRC metastasis.

in vitro and in vivo

[77, 78]

ETBF

recruit tumour-infiltrating

immune cells

ETBF promotes M2 polarization of macrophages, and M2 macrophages can promote CRC metastasis via their secreted proteins and/or regulatory factors.

in vitro

[79]

  

The combined effect of BFT and IL-17 on colonic epithelial cells promotes the differentiation of MO-MDSCs that selectively upregulate Arg1 and Nos2 to producing NO, inhibiting T cell proliferation.

in vivo

[80]

E. coli

recruit tumour-infiltrating

immune cells

E. coli stimulates the secretion of CTSK, which can bind to TLR4, stimulating M2 polarization of TAMs through an mTOR-dependent pathway and promoting CRC metastasis through the NF-κB pathway.

in vitro and in vivo

[81]

  1. Abbreviations: ALPK1, alpha-kinase 1; Arg 1, arginase 1; BFT, Bacteroides fragilis toxin; CCL20, C-C motif chemokine ligand 20; CRC, colorectal cancer; CTSK, cathepsin K; CXCL1, C-X-C motif chemokine ligand 1; DAMP, damage-associated molecular pattern; E. coli, Escherichia coli; ENO1-IT1, enolase1-intronic transcript 1; ETBF, Enterotoxigenic Bacteroides fragilis; F. nucleatum, Fusobacterium nucleatum; ICAM1, intercellular adhesion molecule 1; IL, interleukin; KAT7, lysine acetyltransferase 7; lncRNA, long non-coding RNA; MDSCs, myeloid-derived suppressor cells; MO-MDSCs, monocytic-MDSCs; mTOR, mammalian target of rapamycin; NF-κB, nuclear factor kappa B; NO, nitric oxide; Nos2, inducible nitric oxide synthase 2; p-STAT3, phosphorylated signal transducer and activator of transcription 3; TAMs, tumour-associated macrophages; TLR4, Toll-like receptor 4; TME, tumour microenvironment